Search
Now showing items 1-10 of 707
Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
(Sociedad de Biología de Chile, 2007)
A cyclic peptide derived from α-fetoprotein inhibits the proliferative effects of the epidermal growth factor and estradiol in MCF7 cells
(2008)
A cyclic peptide derived from the active domain of α-fetoprotein (AFP) significantly inhibited the proliferation of MCF7 cells stimulated with the epidermal growth factor (EGF) or estradiol (E 2). The action of these three ...
Cyclosporin but not tacrolimus significantly increases salivary cytokine contents in rats
(2005-09-01)
Background: Cyclosporin (CsA) and tacrolimus (FK-506) are immunosuppressive drugs that specifically inhibit T-cell activation via calcineurin inhibition. Gingival overgrowth is a common side effect following the administration ...
Cyclosporin but not tacrolimus significantly increases salivary cytokine contents in rats
(2005-09-01)
Background: Cyclosporin (CsA) and tacrolimus (FK-506) are immunosuppressive drugs that specifically inhibit T-cell activation via calcineurin inhibition. Gingival overgrowth is a common side effect following the administration ...
Tumor necrosis factor-astimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts
(Blackwell Munksgaard, 2007-12-11)
Membrane type 1-matrix metalloproteinase (MT1-
MMP) is a collagenolytic enzyme involved in connective tissue remodeling. In
periodontal tissues, either cytokines or growth factors regulate the production of
proteolytic ...
Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin
(Blackwell Munksgaard Ltd, 2004-04-08)
Regulation of the extracellular matrix turnover is a crucial process
in wound healing and the progress of periodontal disease. It has been proposed
that urokinase-type plasminogen activator (uPA), under the control of ...